MARKET WIREYahoo Finance UK • 22h ago
DocGo Inc. (DCGO) Seasonal returns chartYahoo Finance UK report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
Why DCGO Stock dropped -13.32% Today — RQD Quant Desk Flash
$0.21 -13.32% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.20
DocGo Inc. (DCGO) carries a Roarable Rating of D- (Sell) with 39/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $24.4M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on DCGO Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is DCGO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, DocGo Inc. (NASDAQ: DCGO) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $0.21 (-13.32% 1D, market cap $24.4M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, DCGO ranks #491 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does DCGO compare to PIII and CCM in the Health Care sector?
▼
Within the Health Care sector (Medical/Nursing Services), DCGO carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, PIII (P3 Health Partners Inc. (Class A)) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $29.3M) and CCM (Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)) posts a E grade (22/100 RQD, P/E N/A, ROIC -35.0%, cap $15.5M). Among the 5-stock peer group, DCGO leads on earnings multiple (N/A) while DCGO leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for DCGO?
▼
Per DCGO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001822359), DocGo Inc. generated $322.2M in revenue (-47.7% YoY), -$196.4M in net income, and $29.9M in free cash flow against $217.1M in total assets and $183.8K in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.20 (-2.59%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 9.3% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (39/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-9.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DCGO)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (39/100 Composite)
🔍 WHY DCGO SCORES 39/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+10/20 pts (26% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (21% of score)
SEC XBRL FY 2025 (10-K): 9.3% FCF Margin ($29.9M FCF) & 52% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)
Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$0.31-16.1% Next Q
47
Q2 (-2Q)Grade D$0.26+3.8% Next Q
44
Q3 (-1Q)Grade D$0.27-22.2% Next Q
42
CurrentGrade D-$0.21-7.6% Hist 90D α
39
Trajectory: D (47) → D- (39)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a DCGO Turnaround Squeeze
While DCGO currently carries a cautious 39/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.34) and Max Pain ($0.22) forces dealer call-delta covering toward $1.22.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $DCGO• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “DCGO Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why DCGO Stock dropped -13.32% Today — RQD Quant Desk Flash
DocGo Inc. (DCGO) dropped -13.32% to $0.21, trading at 2% of its 52-week range ($0.24 – $1.16). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.24 – $1.16) with RSI-14 at 34.8 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.21 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 52% gross margin and $29.9M annual free cash flow.
Live DCGO Headlines & Catalysts
MARKET WIRETradingView • 1d ago
DocGo Secures Up To $102M Term Loans at SOFR+7.5%, Issues 4M Warrants; Terminates Citi RevolverTradingView report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.siam.in/ • 1d ago
DocGo (DCGO) Ticks Up 3.83% to $0.28 as Shares Hug a Tight Support-Resistance Band - Exhaustion Gaphttps://www.siam.in/ report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.dars.gov.et/ • 1d ago
DocGo Inc. (DCGO) Ticks Higher to $0.27 as Buyers Test $0.28 Resistance - Dark Pool Printshttps://www.dars.gov.et/ report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMinichart • 1d ago
DocGo Amends Credit Facility, Ups Term Loans to $102.5M, Issues 4M WarrantsMinichart report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 4d ago
Organon (OGN) Q3 Earnings and Revenues Top EstimatesOrganon (OGN) delivered earnings and revenue surprises of +3.30% and +0.43%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DCGO)
- ✓Walkthrough of DCGO's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
DCGO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -69.12%🛡️ HOLDING TREND SUPPORT
2026-11-03O $0.28H $0.28L $0.21C $0.21VOL 1.72M
RES: $0.77SUP: $0.20SMA50: $0.34SMA200: $0.57
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
DCGO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. -47.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on DCGO today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for DCGO. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DCGO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DCGO)
Health Care Rank #491 of 1015
⚔️ PIII vs DCGO Full Matrix →
1. Head-to-Head Health Care Peer Comparison (DCGO vs. PIII, CCM, EUDA, ALPS)
Industry: Medical/Nursing Services (29 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, DocGo Inc. (DCGO) ranks #491 by composite RQD confidence (39/100, grade D-) and #818 by equity capitalization ($24.4M). Within this direct 5-issuer industry benchmark cohort, DCGO leads on earnings valuation at N/A trailing P/E, while DCGO leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. ALPS currently holds the highest overall quantitative score in the immediate peer group at 52/100 (D+) compared with DCGO at 39/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DCGO
ACTIVE
DocGo Inc. | D- | 39/100 | — | — | -35.0% | -13.32% | $24.4M | Benchmark Subject |
| PIII P3 Health Partners Inc. (Class A) | E | 24/100 | — | — | -35.0% | -0.75% | $29.3M | /piii-vs-dcgo → |
| CCM Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) | E | 22/100 | — | 5.7% | -35.0% | +0.56% | $15.5M | /ccm-vs-dcgo → |
| EUDA EUDA Health Holdings Limited | D- | 39/100 | — | 43.9% | -35.0% | -12.03% | $53.0M | /euda-vs-dcgo → |
| ALPS ALPS Group Inc Ordinary Share | D+ | 52/100 | — | — | — | -0.21% | $54.1M | /alps-vs-dcgo → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001822359 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), DocGo Inc. (DCGO) reported GAAP revenue of $322.2M (-47.7% vs. FY2024 revenue of $616.6M , and -48.4% cumulative change since FY2023) , GAAP net income of -$196.4M, operating cash flow of $34.5M, and free cash flow of $29.9M (-55.0% YoY). On the balance sheet, DCGO closed FY2025 with $217.1M in total assets against $183.8K in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $322.2M | -$196.4M | $34.5M | $29.9M | $217.1M | $183.8K |
| FY2024 (FY) | 2024-12-31 | $616.6M | $13.4M | $70.1M | $66.5M | $455.6M | $5.2K |
| FY2023 (FY) | 2023-12-31 | $624.3M | $10.0M | -$64.5M | -$64.5M | — | — |
3. DCGO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DCGO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, DocGo Inc. (NASDAQ: DCGO) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $0.21 (-13.32% 1D, market cap $24.4M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, DCGO ranks #491 in composite RQD confidence.
How does DCGO compare to PIII and CCM in the Health Care sector?
Within the Health Care sector (Medical/Nursing Services), DCGO carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, PIII (P3 Health Partners Inc. (Class A)) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $29.3M) and CCM (Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)) posts a E grade (22/100 RQD, P/E N/A, ROIC -35.0%, cap $15.5M). Among the 5-stock peer group, DCGO leads on earnings multiple (N/A) while DCGO leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DCGO?
Per DCGO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001822359), DocGo Inc. generated $322.2M in revenue (-47.7% YoY), -$196.4M in net income, and $29.9M in free cash flow against $217.1M in total assets and $183.8K in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DCGO trading relative to its 50-day, 200-day, and 52-week technical levels?
DCGO last traded at $0.21 (-13.32% on volume of 1,409,709 shares), positioning the stock -38.24% below its 50-day simple moving average ($0.34) and -63.16% below its 200-day simple moving average ($0.57). Across its 52-week range of $0.24 to $1.16, DCGO sits at the 0.0% percentile with a 14-day RSI of 34.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.24).
ROARABLE RATING BRIEF • RQD 39/100 (D-)
✓ SEC XBRL & RQD VERIFIED
DCGO — DocGo Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
DocGo Inc. (DCGO) earns a live Roarable RQD composite score of 39/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $0.21 (-13.32% 1D, market capitalization $24.4M).
- Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of —, operating margin of -55.3%, and free cash flow yield of —.
- Whale 13F & Options Flow (10/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (8/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of 0.20, Piotroski F-Score of 5/9, and Debt/Equity of 0.00x.
2. Business Model, Unit Margins & SEC Financial Trajectory
. Is a NASDAQ-listed issuer in the Health Care sector, operating in the Medical/Nursing Services industry. The profile lists a market capitalization of $0.0B, which conflicts with the $27.0M figure in market data.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), DocGo Inc. (DCGO) reported $322.2M in annual revenue (up from $616.6M in FY2024, -47.7% YoY) and -$196.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($624.3M revenue, $10.0M net income) through FY2025, DCGO scaled operating cash flow to $34.5M and free cash flow to $29.9M, backed by $217.1M in total assets against $183.8K in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D- • RQD 39/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 10/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 10/20, sustained execution supports upside toward the upper end of the $0.24 – $1.16 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -55.3% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream and downstream dependencies, sector correlations, and 2nd-order bottlenecks are not mapped in the source data. — Investors should note that the financing items in the news section are the most direct channel by which a debt-funded capital structure could transmit stress to equity holders.
- Key Question #1: Can DCGO sustain or expand its -55.3% operating margin and -35.0% ROIC against Medical/Nursing Services peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $322.2M and free cash flow of $29.9M, how will capital allocation balance growth reinvestment against $183.8K in total debt?
- Key Question #3: How sensitive is DCGO's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
DCGO Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for DocGo Inc. (DCGO) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance UK • 22h ago
DocGo Inc. (DCGO) Seasonal returns chart Yahoo Finance UK report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
DocGo Secures Up To $102M Term Loans at SOFR+7.5%, Issues 4M Warrants; Terminates Citi Revolver TradingView report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.siam.in/ • 1d ago
DocGo (DCGO) Ticks Up 3.83% to $0.28 as Shares Hug a Tight Support-Resistance Band - Exhaustion Gap https://www.siam.in/ report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago
DocGo Inc. (DCGO) Ticks Higher to $0.27 as Buyers Test $0.28 Resistance - Dark Pool Prints https://www.dars.gov.et/ report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Minichart • 1d ago
DocGo Amends Credit Facility, Ups Term Loans to $102.5M, Issues 4M Warrants Minichart report covering DocGo Inc. (DCGO) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo • 4d ago
Organon (OGN) Q3 Earnings and Revenues Top Estimates Organon (OGN) delivered earnings and revenue surprises of +3.30% and +0.43%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
DCGO Bull vs. Bear Conversation Board — What's Your Call at $0.21?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DCGO 🐻 33% BEARISH CONVICTION
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH
🎯 Target: $0.32 (+28.0%)
📌 Pinned Debate Institutional whale 13F flow scores 11/20, the strongest RQD pillar, indicating some accumulation and options positioning support.
Long DCGO at $0.25 targeting $0.32. Institutional whale 13F flow scores 11/20, the strongest RQD pillar, indicating some accumulation and options positioning support.. Institutional whale score is 10/20 and the risk/reward vs. the $0.24 52-week low is skewed heavily in favor of bulls.
VolSurface_Trader 🐂 BULL
@BearTrap_Alert Shorting a 10/20 institutional whale-flow stock at $0.25 is dangerous when funds are rotating into Health Care.
BE BearTrap_Alert RQD DEBATE OPENER • Cycle Peak Watcher 🐻 BEARISH
🎯 Target: $0.20 (-20.0%)
Spot @ $0.25 Altman Z-Score of 0.2 combined with a -35% ROIC and -$196.4M FY 2025 net loss signals severe fundamental and balance-sheet stress.
Here is the bear case nobody on the bull side wants to address on DCGO: Altman Z-Score of 0.2 combined with a -35% ROIC and -$196.4M FY 2025 net loss signals severe fundamental and balance-sheet stress.. At current EV/EBITDA multiples, even a small guidance miss in Medical/Nursing Services triggers a 12-15% air pocket.